New Key Statistics Module, Z-Score and F-Score
NAS:BIOL Key Ratios
| Market Cap $ M | 4.79 |
| Enterprise Value $ M | 16.13 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | -- |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 49.00 |
| EPS (TTM) $ | -37.35 |
| Beneish M-Score | -3.43 |
| 10-y EBITDA Growth Rate % | 36.70 |
| 5-y EBITDA Growth Rate % | 60.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.88 |
| EV-to-EBITDA | -1.04 |
| PEG | -- |
| Shares Outstanding M | 33.26 |
| Net Margin (%) | -41.97 |
| Operating Margin % | -36.48 |
| Pre-tax Margin (%) | -41.90 |
| Quick Ratio | 0.68 |
| Current Ratio | 1.26 |
| ROA % (ttm) | -53.28 |
| ROE % (ttm) | -365.45 |
| ROIC % (ttm) | -93.17 |
| Dividend Yield % | -- |
| Altman Z-Score | -12.69 |
BIOL Number of Guru Trades
BIOL Volume of Guru Trades
Gurus Latest Trades with NAS:BIOL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BIOL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Biolase Inc Insider Transactions
No Available Data
News about NAS:BIOL
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers